- Home
- IMCR vs HLMN Comparison
IMCR vs HLMN Comparison
Compare IMCR & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- HLMN
- Stock Information
- Founded
- IMCR 2008
- HLMN 1964
- Country
- IMCR United Kingdom
- HLMN United States
- Employees
- IMCR N/A
- HLMN N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- HLMN Industrial Machinery/Components
- Sector
- IMCR Health Care
- HLMN Consumer Discretionary
- Exchange
- IMCR Nasdaq
- HLMN Nasdaq
- Market Cap
- IMCR 1.7B
- HLMN 1.9B
- IPO Year
- IMCR 2021
- HLMN N/A
- Fundamental
- Price
- IMCR $37.97
- HLMN $7.97
- Analyst Decision
- IMCR Buy
- HLMN Buy
- Analyst Count
- IMCR 9
- HLMN 6
- Target Price
- IMCR $67.00
- HLMN $12.20
- AVG Volume (30 Days)
- IMCR 270.5K
- HLMN 965.2K
- Earning Date
- IMCR 11-06-2025
- HLMN 11-04-2025
- Dividend Yield
- IMCR N/A
- HLMN N/A
- EPS Growth
- IMCR N/A
- HLMN 388.43
- EPS
- IMCR N/A
- HLMN 0.19
- Revenue
- IMCR $379,590,000.00
- HLMN $1,536,647,000.00
- Revenue This Year
- IMCR $30.11
- HLMN $8.11
- Revenue Next Year
- IMCR $8.89
- HLMN $7.85
- P/E Ratio
- IMCR N/A
- HLMN $42.64
- Revenue Growth
- IMCR 28.11
- HLMN 4.47
- 52 Week Low
- IMCR $23.15
- HLMN $6.55
- 52 Week High
- IMCR $39.33
- HLMN $11.64
- Technical
- Relative Strength Index (RSI)
- IMCR 68.17
- HLMN 21.98
- Support Level
- IMCR $34.30
- HLMN $8.56
- Resistance Level
- IMCR $38.17
- HLMN $8.93
- Average True Range (ATR)
- IMCR 1.54
- HLMN 0.29
- MACD
- IMCR 0.59
- HLMN -0.11
- Stochastic Oscillator
- IMCR 96.54
- HLMN 1.44
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.